Saudi SFDA Rejects Approval of Camel Urine-Based Cancer Treatment Claims
What happened
On October 19, 2026, the Saudi Food and Drug Authority clarified that a camel urine-derived product has not been approved for cancer treatment.
The Context
- Regulatory clarification: The SFDA confirmed the product is only registered as a dietary supplement, not a cancer therapy.
- Cultural beliefs: Traditional use of camel urine for medicinal purposes persists in Saudi Arabia, despite a lack of clinical evidence supporting its efficacy.
- Health risks: Observational studies have shown no clinical benefit for cancer patients and highlighted risks such as zoonotic infections.
The Number
— This is the number of patients who showed clinical benefit in a study of 20 cancer patients using camel urine, underscoring the importance of relying on evidence-based treatments.
Takeaway
Expect continued emphasis on verified medical therapies as misinformation about alternative treatments persists.
English-language reporting on Saudi politics, policy, and society.
"Saudi Gazette reflects mainstream Saudi institutional perspectives."
— A47 Editor
SFDA debunks claims of approved camel urine-derived cancer treatment
The Saudi Food and Drug Authority (SFDA) has refuted claims regarding the approval of a cancer treatment derived from camel urine, clarifying that the product is merely a dietary supplement without therapeutic claims. This clarification comes amidst ...
English-language reporting focused on Saudi Arabia and regional affairs.
"Saudi Gazette provides English-language coverage that often aligns with mainstream Saudi news priorities."
— A47 Editor
SFDA debunks claims of approved camel urine-derived cancer treatment
The Saudi Food and Drug Authority (SFDA) has refuted claims regarding the approval of a cancer treatment derived from camel urine, clarifying that the product is merely a dietary supplement without therapeutic claims. This clarification comes amidst ...
Arabic-language reporting focused on Saudi domestic affairs and current events.
"Al Watan is a mainstream Saudi newspaper with strong domestic coverage and a broad general-news profile."
— A47 Editor
الغذاء والدواء: منتج بول الإبل ليس علاجا للسرطان
The Saudi Food and Drug Authority has denied claims that a product derived from camel urine has been approved as a treatment for cancer, clarifying that it is registered as a dietary supplement containing vitamins and minerals for daily nutritional n...
Arabic-language reporting focused on domestic developments in Saudi Arabia.
"Okaz is a mainstream Saudi newspaper that often reflects domestic priorities and official-facing coverage."
— A47 Editor
«الغذاء والدواء» تنفي اعتماد دواء مستخلص من بول الإبل لعلاج السرطان
The Saudi Food and Drug Authority has denied claims that a medication derived from camel urine has been approved for the treatment of cancer, stating that such assertions are false. The authority clarified that the product in question is registered a...